Skip to main content
. 2010 Mar 12;21(2):91–98. doi: 10.1016/j.cytogfr.2010.02.006

Fig. 3.

Fig. 3

Scheme of delivery of cyclophosphamide and reovirus (REOLYSIN) in phase I study of immunomodulatory therapy. Cyclophosphamide is delivered 3 days before a 5-day cycle of reovirus with cycles repeated each 4 weeks. The −1 dose level was written into the protocol in case dose-limiting toxicity was encountered in cohort 1, but was not needed during study conduct.